GLP-1 (Glucagon-like peptide-1) is a naturally occurring hormone in your gut that acts on various organs, including the pancreas, brain, and, most relevantly here, the stomach and intestines
GSH From Antioxidant to Post-Translational Modifier (PMC, 2016) S-Glutathionylation as a Major Redox Signalling Mechanism A review published in PMC, authored by a leading researcher in the field, documented GSHs evolution in the scientific literature from a simple antioxidant to a key post-translational modifier through S-glutathionylation the reversible formation of mixed disulfides between GSH and protein cysteine residues
Currently, yes semaglutide has proven cardiovascular benefit from the SELECT trial (2023), which demonstrated significant reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with obesity and established heart disease
Renal Outcomes: Rates of new or worsening nephropathy were lower in the semaglutide group compared to the placebo group
Whether you are looking for immune support, cognitive clarity, or skin health, it all starts with building a foundation of trust and high-quality sourcing
